vTv Therapeutics (VTVT) Tops Q3 EPS by 42c
vTv Therapeutics (NASDAQ: VTVT) reported Q3 EPS of ($0.58), $0.42 better than the analyst estimate of ($1.00).
For earnings history and earnings-related data on vTv Therapeutics (VTVT) click here.
vTv Therapeutics (NASDAQ: VTVT) reported Q3 EPS of ($0.58), $0.42 better than the analyst estimate of ($1.00).
For earnings history and earnings-related data on vTv Therapeutics (VTVT) click here.